One small city's bid to rescue its health finances has transformed the way health care is managed across China. Chris McCall ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

A new study published in The Lancet journal showed that Gepotidacin was non-inferior to the standard treatment of ceftriaxone ...

Amycretin is a unimolecular long-acting GLP-1 and amylin receptor agonist under development by Novo Nordisk, to provide an ...

Tom McAndrew, a computational scientist and associate professor in Lehigh's College of Health, recently published a paper in ...

Michelle Monje is the Milan Gambhir Professor of Pediatric Neuro-Oncology at Stanford University, CA, USA, and a Howard ...

The hard lessons the party has learned since Iraq point to one conclusion: Launching a new Middle East war would be a ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

A new study of more than 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long ...